"Understanding these influences may contribute to optimizing work schedules and decreasing variability," NYU experts wrote in the European Journal of Radiology.
Treating severe MR with the popular device does not appear to increase a patient's risk of stroke or transient ischemic attack. When patients present with AFib, however, care teams may want to make certain adjustments to optimize outcomes.
The study's findings indicate that obtaining a prostate MRI at the time of a patient's initial diagnosis may provide important insight into how cancer will progress over time.
Medtronic and Abbott are often seen as rivals in a competitive marketplace, but the two companies are collaborating with a simple goal in mind: improving patient access to high-quality CGM devices.
“Reducing the cost and increasing the accessibility of MRI for [clinically significant prostate cancer] is critical for the viability of MRI screening programs," experts wrote.